Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 213,243 | 231,925 | 14,553 | N/A | N/A |
| Gross Profit | 213,243 | 231,925 | 14,553 | N/A | N/A |
| Operating Expenses | 37,693 | 32,714 | 16,159 | 11,438 | 9,532 |
| Operating Income | 175,550 | 199,211 | -1,606 | -11,438 | -9,532 |
| Other Income | 7,390 | 5,929 | 1,790 | 3,644 | 339 |
| Pre-tax Income | 182,940 | 205,140 | 184 | -7,794 | -9,193 |
| Income Tax | 40,897 | 48,059 | 0 | 0 | 0 |
| Net Income Continuous | 142,043 | 157,081 | 184 | -7,794 | -9,193 |
| Net Income | $142,043 | $157,081 | $184 | $-7,794 | $-9,193 |
| EPS Basic Total Ops | 1.11 | 1.24 | 0.00 | -0.07 | -0.09 |
| EPS Basic Continuous Ops | 1.11 | 1.24 | 0.00 | -0.07 | -0.09 |
| EPS Diluted Total Ops | 1.09 | 1.20 | 0.00 | -0.07 | -0.09 |
| EPS Diluted Continuous Ops | 1.09 | 1.20 | 0.00 | -0.07 | -0.09 |
| EBITDA(a) | $175,572 | $199,228 | $-1,596 | $-11,430 | $-9,526 |